Further processing options
Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
Saved in:
Journal Title: | Annals of Oncology |
---|---|
Authors and Corporations: | , , , , , |
In: | Annals of Oncology, 24, 2013, 10, p. 2543-2548 |
Type of Resource: | E-Article |
Language: | English |
published: |
Elsevier BV
|
Subjects: |